We recently concluded a highly productive, three-day face-to-face workshop for the IMPALA Critical to Quality Assessment Methodology and Report (CAR). The workshop was sponsored by IMPALA and hosted by Boehringer-Ingelheim in Ingelheim, Germany, and brought together the CAR work product team representatives from across our member companies. Our primary goal [...]
PISCATAWAY, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- IMPALA, a global consortium dedicated to advancing digital and analytics-driven quality in biopharmaceutical development, announced the appointment of Ann Marie Dunne, Global Head of R&D Quality and Compliance at Biogen, as its [...]
IMPALA Consortium at DIA 2025 The Drug Information Association (DIA) Global Annual Meeting held in Washington, DC from June 15-19, 2025, brought together pharma industry pioneers, regulatory experts, and healthcare visionaries. The IMPALA (Inter coMPany quALity Analytics) consortium had a [...]
As we wrap up 2024, the IMPALA Consortium reflects on a year of significant progress and achievements in its mission to transform quality in biopharma through the implementation of advance analytics. This year has been marked by impactful work products, [...]
IMPALA is pleased to share it's newest published article in RQA QUASAR #169, November 2024 - Transforming Trial Audits: A Deep Dive Into Data-Driven Clinical Site Audit Selection in Pharmaceuticals. The paper was led by the Audit Site Selection Work Product [...]
